A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2006
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1715858A2 Topical treatment of otitis externa with antifungals or antibacterials
11/02/2006	EP1467761B1 Treatment of neovascular ophthalmic disease
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	CA2814247A1 Polymorphic and amorphous salt forms of squalamine dilactate
11/02/2006	CA2605783A1 Matrix metalloproteinase inhibitors of tgf .beta.-induced subcapsular cataract formation
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2605365A1 Remedy for xanthoma
11/02/2006	CA2605306A1 Therapeutic agent for keratoconjunctival disorder
11/01/2006	CN1856326A Combinations of a VEGF receptor inhibitor with other therapeutic agents
11/01/2006	CN1856308A Excitatory amino acid receptor antagonists
11/01/2006	CN1853727A Polysaccharide-containing compositions and use thereof
11/01/2006	CN1853717A Cyclosporine microball preparation for treating endophthalmitis
11/01/2006	CN1853652A Chinese medicinal gel preparation for treating ophthalmologic disease
11/01/2006	CN1282636C Vitamin D analogues
10/2006
10/31/2006	US7129379 3-amino-propoxphenyl derivatives (l)
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129272 Apoptosis inhibitor
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2209303C Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
10/26/2006	WO2006112442A1 Benzimidazole compound
10/26/2006	WO2006112313A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	WO2006112029A1 Ophthalmic composition
10/26/2006	WO2006111844A1 Use of azithromycin for the production of a medicament for treatment of ocular infections
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241303 Piperidine derivatives and process for their production
10/26/2006	US20060241171 Novel physiologically active substances
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	US20060241062 Method involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060237004 Methods for treating trigeminal neuralgia
10/26/2006	US20060237003 Methods for treating headaches
10/26/2006	CA2604956A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	CA2603833A1 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
10/26/2006	CA2602610A1 Benzimidazole compound
10/25/2006	EP1714965A1 Composition containing solifenacin succinate
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1401496B1 Compositions and methods for treating hyperimmune response in the eye
10/25/2006	EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders.
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1153302B1 Diagnostics and therapeutics for macular degeneration
10/25/2006	CN1852971A Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
10/25/2006	CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006	CN1852729A Antibacterial drug for propionibacterium acnes
10/25/2006	CN1852708A Human beta-defensin secretion promoter
10/25/2006	CN1852700A Triamcinolone acetonide and anecortave acetate formulations for injection
10/25/2006	CN1850274A Nano complex eye drops containing liposoluble compound drug and its preparing method
10/25/2006	CN1850244A Chinese medicine composition for treating eye disease and preparing method
10/25/2006	CN1850218A Chinese medicine composition for treating optic atrophy and preparing method therefor
10/25/2006	CN1850204A Medicine composition for resisting exogenous cold and high fever, and its preparing method
10/25/2006	CN1850191A Eye drops with capillary artemisia, cape jasmine and baikal skullcap root, and its preparing method
10/25/2006	CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006	CN1850119A Erkang powder
10/25/2006	CN1850116A Eye-sight-improving medicine-smell powder
10/25/2006	CN1850087A Effervescent tablet containing cefixime and its preparing method
10/25/2006	CN1850062A Fatty acid eye nano preparations for dry eye disease
10/25/2006	CN1850054A Vitamin A liposome artificial lacrimal eye drops
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281260C Medicinal formulation for treating asthenopia and preparation process thereof
10/25/2006	CN1281229C Eye drop and its preparation
10/25/2006	CN1281211C Use of oxazolidinone in producing medication of treatment fof ocular infections of mammal
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125901 Thiazole derivatives
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125542 Methods and compositions for treating conditions of the eye
10/24/2006	CA2369054C Treatment and control of ocular development
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006108239A1 Ocular drug delivery
10/19/2006	WO2006083841A3 Therapeutic esters
10/19/2006	WO2006060618A3 Topical nepafenac formulations
10/19/2006	US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same

1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 531